Culley Brian M's Form 4 filing
Lineage Cell Therapeutics, Inc. (LCTX) · filed Apr 4, 2022
- Accession no.
- 0001493152-22-009000
- Filed
- Apr 4, 2022
- Trade date
- Mar 31, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $9.79K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Culley Brian MCIK 0001310683 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Common Shares, no par value | MOption exerciseAcquired | +15,450 | – | – | 96,730 | Direct | |
| Mar 31, 2022 | Common Shares, no par value | FTax withholdingDisposed | −5,343 | $1.54 | −$8,228.22 | 91,387 | Direct | |
| Mar 31, 2022 | Common Shares, no par value | PPurchaseAcquired | +6,400 | $1.53 | +$9,792 | 97,787 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Common Shares | MOption exerciseDisposed | −15,450 | $0.00 | $0 | 15,450 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.